Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $16.45 and last traded at $15.40, with a volume of 1005437 shares trading hands. The stock had previously closed at $16.05.
Silverback Therapeutics Trading Down 4.1 %
The company has a market capitalization of $532.58 million, a PE ratio of -6.10 and a beta of 0.60. The company has a fifty day simple moving average of $13.72 and a 200-day simple moving average of $10.94.
Silverback Therapeutics Company Profile
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Further Reading
- Five stocks we like better than Silverback Therapeutics
- Which Wall Street Analysts are the Most Accurate?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What Are Dividends? Buy the Best Dividend Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- ESG Stocks, What Investors Should Know
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
